CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on November 19, 2020
LIXTE BIOTECHNOLGY HOLDINGS, INC.
248 Route 25A, No.2
East Setauket, NY 11733
November 19.2020
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-6010
| Re: | Lixte Biotechnology Holdings, Inc. | |
| Registration Statement on Form S-1 (Reg. No. 333-248588) |
Ladies and Gentlemen:
On behalf of Lixte Biotechnology Holdings, Inc., the undersigned hereby (a) withdraws the previous request that the above referenced Registration Statement be declared effective on Thursday November 19, 2020 and (b) requests that the Securities and Exchange Commission issue an order declaring the Registration Statement effective at 4:00 P.M., Washington, D.C. time, on Monday November 23,2020 or as soon thereafter as is practicable. This will confirm that no securities have been sold pursuant to the Registration Statement. Please call our counsel, David Ficksman, at 310-789-1290 to inform him of the effectiveness.
| Very truly yours, | |
| /s/ John Kovach | |
| John Kovach | |
| President and Chief Executive Officer |